COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Univariable analyses of this multicentre cohort (n=200) found age > 65 years (OR 1.88, 95% 1.00–3.62), being a current/former smoker (4.24, 1.70–12.95), receiving chemotherapy (2.54, 1.09–6.11), and comorbidities (2.65, 1.09–7.46) were associated with increased risk of death.

The Lancet Oncology